The Japanese Ministry of Health, Labour and Welfare has approved zolbetuximab for CLDN18.2-positive, unresectable, advanced or recurrent gastric cancer.
CMTA Board Evolution: Welcoming Bernard Coulie and Kevin Marks streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ The "Japan In-Vitro Diagnostics Market (by Segment and Company), Size, Share, Major Deals, Trends, Company Analysis and Recent Developments -.